Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (21-30 of 599) with videos related to

Pageof 60
Sort By:
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Expert Opinion on Investigational Drugs|December 13, 2019
P<sub>2</sub>-Purinoceptors: Advances and therapeutic opportunitiesMichael Williams, Kenneth A Jacobson
Frontiers in Endocrinology|August 30, 2021
Purinergic Signaling in Liver PathophysiologyShanu Jain, Kenneth A Jacobson
Biomolecules|May 30, 2020
In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y ReceptorsVeronica Salmaso, Kenneth A Jacobson
Frontiers in Pharmacology|June 1, 2023
Editorial: Purinergic pharmacology, Volume IIFrancisco Ciruela, Kenneth A Jacobson
Journal of Computer-Aided Molecular Design|April 5, 2011
Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptorFrancesca Deflorian, Kenneth A Jacobson
Molecular Pharmacology|June 15, 2012
New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptorsKenneth A Jacobson, Stefano Costanzi
Chemmedchem|August 18, 2020
Purinergic Signaling: Impact of GPCR Structures on Rational Drug DesignVeronica Salmaso, Kenneth A Jacobson
Advances in Pharmacology (San Diego, Calif.)|May 19, 2011
Pharmacology of purine and pyrimidine receptors. PrefaceKenneth A Jacobson, Joel Linden
Frontiers in Immunology|May 16, 2022
Optical Control of Adenosine A<sub>3</sub> Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?Francisco Ciruela, Kenneth A Jacobson
Pageof 60

Showing results (21-30 of 599) with videos related to

Sort By:
Pageof 60
Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A Jacobson
Expert Opinion on Investigational Drugs|December 13, 2019
P<sub>2</sub>-Purinoceptors: Advances and therapeutic opportunitiesMichael Williams, Kenneth A Jacobson
Frontiers in Endocrinology|August 30, 2021
Purinergic Signaling in Liver PathophysiologyShanu Jain, Kenneth A Jacobson
Biomolecules|May 30, 2020
In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y ReceptorsVeronica Salmaso, Kenneth A Jacobson
Frontiers in Pharmacology|June 1, 2023
Editorial: Purinergic pharmacology, Volume IIFrancisco Ciruela, Kenneth A Jacobson
Journal of Computer-Aided Molecular Design|April 5, 2011
Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptorFrancesca Deflorian, Kenneth A Jacobson
Molecular Pharmacology|June 15, 2012
New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptorsKenneth A Jacobson, Stefano Costanzi
Chemmedchem|August 18, 2020
Purinergic Signaling: Impact of GPCR Structures on Rational Drug DesignVeronica Salmaso, Kenneth A Jacobson
Advances in Pharmacology (San Diego, Calif.)|May 19, 2011
Pharmacology of purine and pyrimidine receptors. PrefaceKenneth A Jacobson, Joel Linden
Frontiers in Immunology|May 16, 2022
Optical Control of Adenosine A<sub>3</sub> Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?Francisco Ciruela, Kenneth A Jacobson
Pageof 60